TY  - JOUR

T1  - Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies

JO  - Pulmonary Circulation

UR  - https://eprints.whiterose.ac.uk/id/eprint/210817

PY  - 2024/03/17

AU  - Varian F

AU  - Dick J

AU  - Battersby C

AU  - Roman S

AU  - Ablott J

AU  - Watson L

AU  - Binmahfooz S

AU  - Zafar H

AU  - Colgan G

AU  - Cannon J

AU  - Suntharalingam J et al

ED  - 

DO  - DOI: 10.1002/pul2.12337

PB  - Wiley

VL  - 14

IS  - 1

Y2  - 2024/09/20

ER  -